Key result
Calcific mitral stenosis was associated with fewer good functional results 20 years after percutaneous mitral commissurotomy compared to noncalcified valves (12% vs 38%; HR 2.5; P<0.0001).
Why the study?
Does valve calcification worsen long-term functional outcomes after percutaneous mitral commissurotomy in patients with rheumatic mitral stenosis?
Cohort (n=1,024)
Does valve calcification worsen long-term functional outcomes after percutaneous mitral commissurotomy in patients with rheumatic mitral stenosis?
Although long-term functional outcomes of percutaneous mitral commissurotomy are worse in patients with calcific mitral stenosis compared to those with noncalcified valves, selected patients with less severe calcification still achieve acceptable results, supporting its use as a first-line treatment.
May warrant cautious patient selection for percutaneous mitral commissurotomy in calcific cases; leaves open whether alternatives improve long-term outcomes.
BACKGROUND: Indications of percutaneous mitral commissurotomy (PMC) remain debated in calcific mitral stenosis. We analyzed long-term results of PMC for calcific mitral stenosis and the factors associated with late functional results. METHODS AND RESULTS: We compared the characteristics and outcome of 314 patients undergoing PMC for calcific mitral stenosis with 710 patients with noncalcified valves followed up to 20 years. Calcification was defined by fluoroscopy, and its extent was graded from 1 to 4. Good immediate results (valve area ≥ 1.5 cm(2) with mitral regurgitation ≤ 2/4) were obtained in 251 patients (80%) with calcified valves and 661 (93%) with noncalcified valves (P < 0.001). The hazard ratio for good functional results (survival without cardiovascular death, without mitral reintervention, and in New York Heart Association class I or II) was 2.5 (95% confidence interval [2.1-2.9]; P < 0.0001) in patients with calcified valves (12 ± 3% at 20 years) relative to the noncalcified group (38 ± 2% at 20 years). In the 251 patients with calcified valves who had good immediate results, 15-year rates of good functional results were 35 ± 4% for minor (grade 1) calcification, 24 ± 6% for grade 2, and 10 ± 6% for severe (grades 3-4) calcification. Factors associated with poor late functional results on multivariable analysis were calcification extent, older age, higher New York Heart Association class, atrial fibrillation, and higher mean gradient after PMC. CONCLUSIONS: Although late results of PMC are less satisfying in calcific mitral stenosis, long-term functional outcome depends on calcification extent, patient characteristics, and immediate results of PMC. These findings support the use of PMC as first-line treatment in selected patients with calcific mitral stenosis.
No takes yet. Share an insight, caveat, or question.
Bouleti et al. (2014) conducted a cohort in Rheumatic mitral stenosis (n=1,024). Calcified mitral valves vs. Noncalcified mitral valves was evaluated on Good functional results (survival without cardiovascular death, without mitral reintervention, and in New York Heart Association class I or II) (HR 2.5, 95% CI 2.1-2.9, p=<0.0001). Calcific mitral stenosis was associated with fewer good functional results 20 years after percutaneous mitral commissurotomy compared to noncalcified valves (12% vs 38%; HR 2.5; P<0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: